Mounting evidence from various laboratories has indicated that malignant tumors, in contrast to benign tumors, express a high level of CXCR4 and the level of CXCR4 is correlated with metastasis to distant organs and reduced overall survival [10, 11]. Here, CXCR4 is linked to benign neoplasm.